Skip to content

Acupuncture Treatment for Improving Alzheimer's Dementia

Clinical Trial to Measure Efficacy of Acupuncture Treatment for Alzheimer's Dementia as Measured by MOCA(Montreal Cognitive Assessment)

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04064021
Enrollment
0
Registered
2019-08-21
Start date
2025-01-01
Completion date
2027-03-31
Last updated
2022-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Cognitive Deficits

Keywords

Acupunture

Brief summary

Evaluate cognitive improvement pre amd post acupuncture treatment in patients with probable alzheimer's dementia as measured by MOCA score and also per form A( measure of patient's personal information). Also caregiver input.

Detailed description

Patient's with diagnosis of probable mild to moderate AD will be enrolled in this study. Patient will undergo neurological examination including MOCA. Examiner will also fill out Form A at the time of initial evaluation. Patient will then undergo series of acupuncture treatments 2 per week for 6 weeks(12 acupuncture treatment). At end of this intervention patients will be reassessed using same testing(MOCA and form A) Data collected will be assessed via statistical analysis to see if there is any statistically significant improvement. Acupuncture points used in this trial will stay the same for all subjects and throughout the course. The points will be Si Shen Chong, ST36, 37, LV 2,3,6, GB 34, 39, Xia San Huang, LI 11, LI 4.

Interventions

PROCEDUREAcupunture

Patient will receive 12 acupuncture treatments over 6 weeks (2x per week)

Sponsors

N & S Neurology Center, A Medical Group, Inc
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Mild to moderate AD

Exclusion criteria

* Severe AD

Design outcomes

Primary

MeasureTime frameDescription
Improvement on Montreal Cognitive Assessment test of 5 points or more than baseline( total score is out of 30 points)12 weeksSubject will complete 3 MOCA assessment prior to study over 1 week time. Best score of three is used. After study is complete subject will also undergo 3 MOCA assessment over 1 week immediately after study. Again best score is used.

Secondary

MeasureTime frameDescription
Improvement of Montreal Cognitive Assessment test by category than raw total score12 weeksperformance on various subcategory will also be reviewed to see if one category improves over other category. (Example: Visual-spacial parameters improves over language)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026